Sponsor:
Kartos Therapeutics, Inc.
Code:
NCT04640532
Conditions
Myelofibrosis
Post-PV MF
Post-ET Myelofibrosis
Primary Myelofibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
KRT-232
TL-895
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Kartos Therapeutics, Inc. on 2022-05-09.